Format

Send to

Choose Destination

See 1 citation found using an alternative search:

Infect Dis Clin North Am. 2016 Mar;30(1):207-27. doi: 10.1016/j.idc.2015.10.009.

Histoplasmosis.

Author information

1
MiraVista Diagnostics, 4705 Decatur Boulevard, Indianapolis, IN 46241, USA. Electronic address: jwheat@miravistalabs.com.
2
Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA.
3
Division of Infectious Diseases, University of Kansas, 3901 Rainbow Boulevard, Mailstop 1028, Kansas City, KS 66160, USA.
4
Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, Saint Louis, MO 63110, USA.
5
Division of Clinical Microbiology, Department of Pathology and Laboratory Medicine, IU Health Pathology Laboratory, Indiana University School of Medicine, 350 West 11th Street, Indianapolis, IN 46202, USA.
6
Methodist Professional Center-1, Suite 230, 1801 N Senate Boulevard, Indianapolis, IN 46202, USA.

Abstract

Although histoplasmosis is highly endemic in certain regions of the Americas, disease may be seen globally and should not be overlooked in patients with unexplained pulmonary or systemic illnesses. Most patients exhibit pulmonary signs and symptoms, accompanied by radiographic abnormalities, which often are mistaken for community-acquired pneumonia caused by bacterial or viral agents. Once a diagnosis is considered, a panel of mycologic and non-culture-based assays is adequate to establish a diagnosis in a few days to a week in most patients. Once diagnosed, the treatment is highly effective even in immunocompromised patients.

KEYWORDS:

Antibody; Antigen; Central nervous system; Disseminated; Histoplasma; Histoplasmosis; Pulmonary; Serology

PMID:
26897068
DOI:
10.1016/j.idc.2015.10.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center